Deletion of <i>iscR</i> decreases <i>K. pneumoniae</i> Δ<i>fur</i> siderophore production assessed using CAS assay. by Chien-Chen Wu (281137)

Data Sheet 1_Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study.docx by Jie Gao (10266)

A fitted regression model that shows the relationship between distillation time (DT) and the concentration (%) of (A) β-caryophyllene, (B) maaliol, (C) germacrene D-4-ol, (D) spath... by Valtcho D. Zheljazkov (627617)

The data of meta-analysis. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Quality assessment for risk of bias for studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Effect of tirzepatide vs placebo on body weight. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

The results of safety in meta-analysis. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Graphs of risk of bias for studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

General baseline of included studies. by Fei Lin (156666)

“…<div><p>Objective</p><p>Tirzeptide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drug, which shows good efficiency for weight loss. …”

Splenic DCs of the oxATP recipients have decreased ability to produce IL-23 and IL-6 and were poor stimulators for Th17 autoreactive T cells. by Ronglan Zhao (658986)

Genetic context and molecular phylogenetic analysis of SrpM. by Nicolas Carraro (650366)

<i>Rfx4</i>^-/- embryos at E12.5 and E14.5 exhibit holoprosencephaly. by Ping Xu (122619)

“…<p>Note the complete absence of the developing cerebral hemispheres (CH) in the KO embryo seen in A-C. There was a striking decrease in size of all regions of the brain, but especially the developing midbrain in (D). …”

Values for the calculation of the time-dependent drug concentrations in the system based on observed data found and derived from a variety of sources. by J. Roadnight Sheehan (20141887)

A Family of Octahedral Rhenium Cluster Complexes [Re₆Q₈(H₂O)<i>_n</i>(OH)₆_-<i>_n<... by Konstantin A. Brylev (1379436)

Image 1_A comprehensive immune repertoire signature distinguishes pulmonary infiltration in SARS-CoV-2 Omicron variant infection.jpeg by Xuechuan Li (14430114)

“…</p>Results<p>Patients with pulmonary infiltration exhibit lymphopenia, a decreased proportion of the overall TCR repertoire alongside an increased BCR repertoire, reduced IGHD and IGHM isotype expression, a shorter mean CDR3 length for TRG, and a longer mean length for TRD, as well as diminished clonality and diversity in the TCR/BCR repertoire. …”

An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals by Dominique Detaille (3768979)

“…<div><p>Findings</p><p>Here, we demonstrate that OP2113 (5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione, CAS 532-11-6), synthesized and used as a drug since 1696, does not act as an unspecific antioxidant molecule (i.e., as a radical scavenger) but unexpectedly decreases mitochondrial reactive oxygen species (ROS/H₂O₂) production by acting as a specific inhibitor of ROS production at the I_Q site of complex I of the mitochondrial respiratory chain. …”

Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein but increases of intrathecal axonal degradation products and TGF-β in patients with cerebral lupus by Estelle Trysberg (58614)

DataSheet_1_Citrus reticulatae pericarpium Extract Decreases the Susceptibility to HFD-Induced Glycolipid Metabolism Disorder in Mice Exposed to Azithromycin in Early Life.docx by Hanqi Lu (8563149)

“…</p>Methods and Results<p>Three-week-old mice were treated with AZT (50 mg/kg/day) via drinking water for two weeks and then were fed a CRP diet (1% CRP extract) for four weeks and an HFD for five weeks. …”

Table_1_Comparison of the First and Second Wave of Infections by SARS-CoV-2: A Retrospective and Longitudinal Study From a Primary Health Care Center in Santiago of Chile.docx by Claudio Acuña-Castillo (512379)

“…In addition, we observed that infections in the second wave were mainly in young patients with reduced comorbidities. The population with a complete vaccination schedule shows a decrease in the duration of symptoms related to the disease, and patients with more comorbidities tend to develop severe illness. …”

IQGAP1 is a protein that plays a critical role in regulating the level of apoptosis in endothelial cells. by Shaojun Huang (12489901)

“…<p>(A) The Annexin V–FITC/propidium iodide (PI) assay results indicate that Si-IQGAP1 can slightly decrease the apoptosis rate of normal cells, whereas knocking down IQGAP1 in PA-induced cells (PA + Si-IQGAP1) can significantly reduce the apoptosis rate. …”